N-Ethylmaleimide inhibition of thrombin-induced platelet aggregation

Biochemical Pharmacology

Volumn 58, Issue 8, 1999, Pages 1293-1299

  Leoncini, Giuliana ^a   Signorello, Maria Grazia ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Aggregation; Cyclic nucleotides; Human platelets; NEM; Thrombin

Indexed keywords

ANTITHROMBOCYTIC AGENT; CYCLIC AMP; CYCLIC AMP PHOSPHODIESTERASE; CYCLIC GMP; CYCLIC NUCLEOTIDE; MYOSIN LIGHT CHAIN; N ETHYLMALEIMIDE;

ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STIMULATION; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION;

EID: 0032865959     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00205-1     Document Type: Article

References (28)

1. Staal F.J.T., Anderson M.T., Staal G.E.J., Herzenberg L.A., Gitler C., Herzenberg L.A. Redox regulation of signal transduction Tyrosine phosphorylation and calcium influx . Proc Natl Acad Sci USA. 91:1994;3619-3622.
2. Stahls A. The sulfhydryl reagent N-ethylmaleimide induces hyperphosphorylation on tyrosine residues in the Jurkat T-cell line. Biochem Biophys Res Commun. 187:1992;73-78.
3. Clark S., Konstantopoulos N. Sulphydryl agents modulate insulin- and epidermal growth factor (EGF)-receptor kinase via reaction with intracellular receptor domains Differential effect on basal versus activated receptors . Biochem J. 292:1993;217-223.
4. 2 in endothelial cells. Biochem Pharmacol. 49:1995;57-63.
5. Leoncini G., Signorello M.G. N-ethylmaleimide-stimulated arachidonic acid release in human platelets. Biochem Pharmacol. 57:1999;785-791.
6. 3H]noradrenaline release from rabbit hippocampus synaptosomes. Neurochem Int. 17:1990;149-155.
7. i-mediated inhibition of human platelet adenylate cyclase by thrombin. Eur J Biochem. 145:1984;333-338.
8. Grandt R., Aktories K., Jakobs K.H. Evidence for two GTPases activated by thrombin in membranes of human platelets. Biochem J. 237:1986;669-674.
9. Hoshino S., Kikkawa S., Takahashi K., Itoh H., Kaziro Y., Kawasaki H., Suzuki K., Katada T., Ui M. Identification of sites for alkylation by N-ethylmaleimide and pertussis toxin-catalysed ADP ribosylation on GTP-binding proteins. FEBS Lett. 276:1990;227-231.
10. Leoncini G., Maresca M., Buzzi E., Piana A., Armani U. Platelets of patients affected with essential thrombocythemia are abnormal in plasma membrane and adenine nucleotide content. Eur J Haematol. 44:1990;115-119.
11. Born G.V.R. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 194:1962;927-929.
12. Leoncini G., Signorello M.G., Roma G., Di Braccio M. Effect of 2-(1-piperazinyl)-4H-pyrido[1,2-a] pyrimidin-4-one (AP155) on human platelets in vitro. Biochem Pharmacol. 53:1997;1667-1672.
13. Rotondo S., Evangelista V., Manarini S., De Gaetano G., Cerletti C. Different requirement of intracellular calcium and protein kinase C for arachidonic acid release and serotonin secretion in cathepsin G-activated platelets. Thromb Haemost. 78:1997;919-925.
14. Maurice D.H., Haslam R.J. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase inhibition of cyclic AMP breakdown by cyclic GMP . Mol Pharmacol. 37:1991;671-681.
15. Akkermann J.W.N. Inhibition of platelet functions by cyclic 3′, 5′ AMP. Platelets. 7:1996;342-344.
16. Siess W. Molecular mechanisms of platelet activation. Physiol Rev. 69:1989;58-178.
17. Tang K.M., Sherwood J.L., Haslam R.J. Photoaffinity labelling of cyclic GMP-binding proteins in human platelets. Biochem J. 294:1993;329-333.
18. Horstrup K., Jablonka B., Honig-Liedl P., Just M., Kochsiek K., Walter U. Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser 157 in intact human platelets correlates with fibrinogen receptor inhibition. Eur J Biochem. 225:1994;21-27.
19. Brass L.F., Manning D.R., Williams A.G., Woolkalis M.J., Poncz M. Receptor and G protein-mediated responses to thrombin in HEL cells. J Biol Chem. 266:1991;958-965.
20. i in control of thrombin receptor-phospholipase C coupling in human platelets. J Biol Chem. 263:1988;3363-3371.
21. 2+ release by cAMP-dependent protein kinase in a living cell. Proc Natl Acad Sci USA. 95:1998;1613-1617.
22. Geiger J., Nolte C., Butt E., Sage S.O., Walter U. Role of cGMP and cGMP-dependent protein kinase in nitrovasodilator inhibition of agonist-evoked calcium elevation in human platelets. Proc Natl Acad Sci USA. 89:1992;1031-1035.
23. Ruth P., Wang G.X., Boekhoff I., May B., Pfeifer A., Penner R., Korth M., Breer H., Hofmann F. Transfected cGMP-dependent protein kinase suppresses calcium transients by inhibition of inositol 1,4,5-trisphosphate production. Proc Natl Acad Sci USA. 90:1993;2623-2627.
24. Wang G.R., Zhu Y., Halushka P.V., Lincoln T.M., Mendelsohn M.E. Mechanism of platelet inhibition by nitric oxide In vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase . Proc Natl Acad Sci USA. 95:1998;4888-4893.
25. Fox J.E.B. Platelet contractile proteins. Phillips D.R., Shuman M.A. Biochemistry of Platelets. 1986;115-157 Academic Press, New York.
26. Sandberg M., Butt E., Nolte C., Fisher L., Halbrügge M., Beltman J., Jahnsen T., Genieser H.G., Jastorff B., Walter U. Characterization of Sp-5,6-dichloro-1-β-D-ribofuranosyl-benzimidazolo-3′, 5′-monophosphorothioate (Sp-5, 6-DCI-cBiMPS) as a potent and specific activator of cyclic-AMP-dependent protein kinase in cell extracts and intact cells. Biochem J. 279:1991;521-527.
27. Siess W., Lapetina E.G. Functional relationship between cyclic AMP-dependent protein phosphorylation and platelet inhibition. Biochem J. 271:1990;815-819.
28. Waldmann R., Bauer S., Gobel C., Hofmann F., Jacobs K.H., Walter U. Demonstration of cGMP-dependent phosphorylation in cell-free extracts of platelets. Eur J Biochem. 158:1986;203-210.